4.7 Article

Selective killing of candidate AML stem cells by antibody targeting of IL1RAP

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Charles A. Dinarello et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Article Medicine, Research & Experimental

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2R gamma c-deficient mice

Jean-Emmanuel Sarry et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Biochemistry & Molecular Biology

Stem cell gene expression programs influence clinical outcome in human leukemia

Kolja Eppert et al.

NATURE MEDICINE (2011)

Article Multidisciplinary Sciences

Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein

Marcus Jaras et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Immunology

Immunological and Inflammatory Functions of the Interleukin-1 Family

Charles A. Dinarello

ANNUAL REVIEW OF IMMUNOLOGY (2009)